Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$28.5 - $39.37 $1.21 Million - $1.67 Million
-42,400 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$30.22 - $45.57 $154,756 - $233,363
-5,121 Reduced 10.78%
42,400 $1.29 Million
Q4 2020

Feb 02, 2021

BUY
$23.5 - $52.65 $7,520 - $16,848
320 Added 0.68%
47,521 $1.81 Million
Q3 2020

Nov 05, 2020

BUY
$18.85 - $27.0 $151,855 - $217,512
8,056 Added 20.58%
47,201 $1.09 Million
Q2 2020

Aug 12, 2020

BUY
$9.76 - $25.95 $278,423 - $740,275
28,527 Added 268.67%
39,145 $973,000
Q4 2019

Jan 27, 2020

BUY
$11.61 - $17.21 $123,274 - $182,735
10,618 New
10,618 $152,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $631M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.